- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Altamira Therapeutics Ltd (CYTOF)
Altamira Therapeutics Ltd stock price live, this page displays OTC CYTOF stock exchange data. View the CYTOF premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Altamira Therapeutics Ltd real time stock price chart below.
What Is the Altamira Therapeutics Ltd Stock Price Today?
The Altamira Therapeutics Ltd stock price today is 0.071.
What Is the Stock Symbol for Altamira Therapeutics Ltd?
The stock symbol for Altamira Therapeutics Ltd is "CYTOF."
What Stock Exchange Does Altamira Therapeutics Ltd Trade On?
Altamira Therapeutics Ltd is listed and trades on the OTC Markets stock exchange.
Is Altamira Therapeutics Ltd a Good Stock to Buy?
Determining whether Altamira Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYTOF quote. (ISIN: BMG0360L1349)
What Is the Altamira Therapeutics Ltd Stock Price Today?
The Altamira Therapeutics Ltd stock price today is 0.071.
What Is the Stock Symbol for Altamira Therapeutics Ltd?
The stock symbol for Altamira Therapeutics Ltd is "CYTOF."
What Stock Exchange Does Altamira Therapeutics Ltd Trade On?
Altamira Therapeutics Ltd is listed and trades on the OTC Markets stock exchange.
Is Altamira Therapeutics Ltd a Good Stock to Buy?
Determining whether Altamira Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYTOF quote. (ISIN: BMG0360L1349)
OTC Markets
Currency in USD
0.071
-0.003(-4.06%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.071
0.077
52 wk Range
0.050
0.148
CYTOF is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0710.077
52 wk Range
0.0500.148
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CYTOF Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
CYTO stock plunges to 52-week low, touches $0.4- Investing.com
CYTO stock plunges to 52-week low, touches $0.4- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Aug 29, 2025
EPS / Forecast
-0.31 / --
Revenue / Forecast
-- / --
Compare CYTOF to Peers and Sector
Metrics to compare | CYTOF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCYTOFPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −3.4x | −0.3x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.1x | 0.9x | 2.6x | |
Price / LTM Sales | - | 31.9x | 3.0x | |
Upside (Analyst Target) | - | 172.8% | 53.8% | |
Fair Value Upside | Unlock | 0.0% | 8.6% | Unlock |
Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland, Australia, the United States, and Europe. The company develops and supplies peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues through xPhore platform; and offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens It is also developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid arthritis; and AM-125 that is in post phase II clinical trial for the intranasal treatment of vertigo. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. The company was founded in 2003 and is based in Hamilton, Bermuda.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Altamira Therapeutics (CYTOF) Stock Price Today?
The Altamira Therapeutics stock price today is 0.071 USD.
What Stock Exchange Does Altamira Therapeutics Trade On?
Altamira Therapeutics is listed and trades on the OTC Markets.
What Is the Stock Symbol for Altamira Therapeutics?
The stock symbol for Altamira Therapeutics is "CYTOF."
What Is the Altamira Therapeutics Market Cap?
As of today, Altamira Therapeutics market cap is 405.000K USD.
What Is Altamira Therapeutics's Earnings Per Share (TTM)?
The Altamira Therapeutics EPS (TTM) is -1.311.
From a Technical Analysis Perspective, Is CYTOF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Altamira Therapeutics Stock Split?
Altamira Therapeutics has split 5 times.
How Many Employees Does Altamira Therapeutics Have?
Altamira Therapeutics has 11 employees.
What is the current trading status of Altamira Therapeutics (CYTOF)?
As of Sep 11, 2026, Altamira Therapeutics (CYTOF) is trading at a price of 0.071 USD, with a previous close of 0.071 USD. The stock has fluctuated within a day range of 0.071 USD to 0.077 USD, while its 52-week range spans from 0.050 USD to 0.148 USD.
What Is the CYTOF After Hours Price?
CYTOF's last after hours stock price is 0.138 USD, the stock has decreased by 0.038, or 38.050%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.